Cassava Sciences hit with FDA request for more data on simufilam trial
Cassava Sciences (SAVA) said in a filing the FDA has asked for more information before allowing its investigational new...
News / Analytics / Reviews
Cassava Sciences (SAVA) said in a filing the FDA has asked for more information before allowing its investigational new...
Cassava Sciences has popped 10% in after-market-close trading Monday following an SEC filing indicated that CEO Richard...
Shares of Cassava Sciences (SAVA) added ~5% in the premarket on Friday after Richard Barry, President and Chief Executive...
Cassava Sciences (SAVA) has filed a shelf registration statement with the SEC to offer up to $200 million worth of mixed...
Cassava Sciences (NASDAQ:SAVA) shares rose as much as 6% premarket on Friday after a U.S. court dismissed a criminal case...
Cassava Sciences (NASDAQ:SAVA) president & CEO Richard Barry has disclosed a purchase of 237,941 shares of the...
Cassava Sciences press release (NASDAQ:SAVA): Q2 GAAP EPS of -$0.92. Cash and cash equivalents were $112.4 million, with no...
Cassava Sciences (NASDAQ:SAVA) has appointed Joseph Hulihan as chief medical officer. He will devote approximately half of...
Vladimir ZakharovAs part of its 37th annual reconstitution, FTSE Russell announced preliminary additions and deletions for...
Vladimir ZakharovKicking off its 37th annual reconstitution, FTSE Russell has published preliminary lists of companies to be...